Eukaryotic DNA replication uses kinase regulatory pathways to facilitate coordination with other processes during cell division cycles and response to environmental cues. At least two cell cycleregulated protein kinase systems, the S-phase-specific cyclindependent protein kinases (S-CDKs) and the Dbf4-Cdc7 kinase (DDK, Dbf4-dependent protein kinase) are essential activators for initiation of DNA replication [1] [2] [3] [4] [5] . Although the essential mechanism of CDK activation of DNA replication in Saccharomyces cerevisiae has been established 6,7 , exactly how DDK acts has been unclear. Here we show that the amino terminal serine/threoninerich domain (NSD) of Mcm4 has both inhibitory and facilitating roles in DNA replication control and that the sole essential function of DDK is to relieve an inhibitory activity residing within the NSD. By combining an mcm4 mutant lacking the inhibitory activity with mutations that bypass the requirement for CDKs for initiation of DNA replication, we show that DNA synthesis can occur in G1 phase when CDKs and DDK are limited. However, DDK is still required for efficient S phase progression. In the absence of DDK, CDK phosphorylation at the distal part of the Mcm4 NSD becomes crucial. Moreover, DDK-null cells fail to activate the intra-S-phase checkpoint in the presence of hydroxyurea-induced DNA damage and are unable to survive this challenge. Our studies establish that the eukaryote-specific NSD of Mcm4 has evolved to integrate several protein kinase regulatory signals for progression through S phase.
Eukaryotic DNA replication uses kinase regulatory pathways to facilitate coordination with other processes during cell division cycles and response to environmental cues. At least two cell cycleregulated protein kinase systems, the S-phase-specific cyclindependent protein kinases (S-CDKs) and the Dbf4-Cdc7 kinase (DDK, Dbf4-dependent protein kinase) are essential activators for initiation of DNA replication [1] [2] [3] [4] [5] . Although the essential mechanism of CDK activation of DNA replication in Saccharomyces cerevisiae has been established 6, 7 , exactly how DDK acts has been unclear. Here we show that the amino terminal serine/threoninerich domain (NSD) of Mcm4 has both inhibitory and facilitating roles in DNA replication control and that the sole essential function of DDK is to relieve an inhibitory activity residing within the NSD. By combining an mcm4 mutant lacking the inhibitory activity with mutations that bypass the requirement for CDKs for initiation of DNA replication, we show that DNA synthesis can occur in G1 phase when CDKs and DDK are limited. However, DDK is still required for efficient S phase progression. In the absence of DDK, CDK phosphorylation at the distal part of the Mcm4 NSD becomes crucial. Moreover, DDK-null cells fail to activate the intra-S-phase checkpoint in the presence of hydroxyurea-induced DNA damage and are unable to survive this challenge. Our studies establish that the eukaryote-specific NSD of Mcm4 has evolved to integrate several protein kinase regulatory signals for progression through S phase.
In the early 1970s, studies on fusion of human cells indicated that DNA in G1 nuclei was competent for initiation of DNA replication, but G1 cells lacked an activator(s) that was present in S phase cells 8 . The competent state has been defined as licensing of replication origins before S phase 1, 5, 9, 10 . The process occurs at the M-phase exit through G1 phase, when a pre-replicative complex forms at each origin. Pre-replicative complex assembly begins with the binding of the origin recognition complex (ORC), which recruits more protein factors, and ultimately completes with the loading of the minichromosome maintenance (MCM) complex. Subsequently S-phasespecific kinases, S-CDKs and DDK, activate this competent state by promoting assembly of the CMG complex (Cdc45, MCM and GINS), the active replicative helicase [11] [12] [13] . The minimal set of S-CDK targets essential for initiation of replication has been identified 6, 7 . S-CDKs phosphorylate Sld2 and Sld3, enabling them to bind to Dpb11 6, 7, 14 . Genetic and biochemical evidence indicated the MCM complex as one DDK target 3, 4 . In budding yeast, DDK phosphorylates several MCM subunits and a mutation in MCM5, mcm5-bob1, can survive without DDK [15] [16] [17] [18] [19] .
DDK binds to Mcm4 via a kinase-docking domain, allowing processive phosphorylation of several sites within the adjacent 174 amino acid NSD 18 . Because deletion of NSD does not prevent cells from initiating DNA replication, it is likely that the role of NSD is regulatory. One hypothesis is that the NSD of Mcm4 blocks the activation of licensed origins and phosphorylation of the NSD by DDK alleviates the inhibition. To test this idea, we replaced the chromosomal MCM4 with mcm4 D2-174 , which lacks the entire NSD, in the temperature sensitive (ts) DDK mutants cdc7-4 and dbf4-1. Deletion of the Mcm4 NSD rescued the ts defect of cdc7-4 or dbf4-1 ( Fig. 1a ). Moreover, cdc7D mcm4 D2-174 cells were viable ( Supplementary Fig. 1 ). The cdc7D mcm4 D2-174 cells, however, grow slowly, probably either due to (1) residues 2-174 harbouring a domain needed for optimal MCM functions, or (2) DDK having another function in addition to its essential role in regulating Mcm4. Nevertheless, removing the Mcm4 NSD allows cells to bypass the essential function of DDK.
The ability of mcm4 D2-174 to bypass DDK is recessive to MCM4. Reintroducing an MCM4 vector into dbf4-1 mcm4 D2-174 allows cells to grow better at the permissive temperature (22 uC), but they did not grow at 37 uC, in contrast to the empty vector ( Fig. 1b) . Moreover, the MCM4 plasmid, unlike the empty vector, failed to yield transformed colonies in cdc7-4 mcm4 D2-174 or cdc7D mcm4 D2-174 cells, whereas CDC7 efficiently rescued cdc7D mcm4 D2-174 cells ( Supplementary  Fig. 2a, b ). Together, these results indicate that the Mcm4 NSD contains an inhibitory activity that renders DDK essential for viability. Therefore, we used transformation of cdc7D mcm4 D2-174 cells as an assay to map the inhibitory activity. Whereas transformation of the mcm4 D74-174 plasmid or empty vector yielded numerous colonies, transformation of plasmids carrying either MCM4, mcm4 D2-73 or mcm4 D2-145 produced none ( Fig. 1c and Supplementary Fig. 2c ). Thus, the inhibitory activity resides within 74-174 of Mcm4 and residues 146-174 are sufficient for inhibiting transformation of cdc7D mcm4 D2-174 cells. We have previously demonstrated DDK target sites within the 146-174 region 18 . Here, we found that the phosphomimetic mutation constructs (mcm4 D2-145, 5D12D or mcm4 D2-145, 4D12D ) produced many transformed colonies, whereas a construct that could not be phosphorylated by DDK (mcm4 D2-145, 5A12A ) failed to produce transformants in cdc7D mcm4 D2-174 cells ( Fig. 1c and Supplementary  Fig. 2c ). Thus, at least a portion of the Mcm4 NSD proximal to the DDK docking domain is inhibitory and phosphorylation of this region by DDK antagonizes the inhibitory effect.
We tested those mcm4 alleles without the inhibitory activity for DDK bypass using a modified plasmid shuffle assay ( Fig. 2a ; see legend). This assay is stringent and relies on a centromere (CEN)-based plasmid with a single replication origin to carry the tested allele. Thus, only those mcm4 alleles that can both fulfil the function of Mcm4 and bypass the requirement for DDK efficiently would allow the tester strain to survive on 5-fluoroorotic acid (5-FOA) medium. Plasmids carrying mcm4 D74-174 , mcm4 D2-145, 5D12D and mcm4 D2-145, 4D12D allowed growth on 5-FOA media, indicating that these mutant alleles can cope with simultaneous loss of both MCM4 and CDC7 genes. In contrast, plasmids carrying CDC7, MCM4, mcm4 D2-174 , mcm4 D2-73 , mcm4 D2-145 and mcm4 D2-145,5A12A scored negative in this assay.
Although unphosphorylated mcm4 D2-145 seems to be sufficient for exerting the inhibitory effect ( Fig. 1c ), the inhibitory domain extends beyond residues 146-174 because mcm4 D147-174 , mcm4 D123-174 or mcm4 D98-174 also fail to support DDK-independent growth (Supplementary Fig. 3 ). Importantly, alanine substitution of 11 potential DDK phosphorylation sites within 74-174 in the full length NSD is lethal even in the presence of DDK ( Supplementary Fig. 4 ). It is possible that, when unphosphorylated, the proximal portion of the NSD exerts its inhibitory effect by imposing on the MCM complex a conformation that is not permissive for recruitment of activating factors, such as Cdc45 and GINS, and phosphorylation by DDK or removal of this domain allows the complex to assume a permissive state. The NSD inhibitory domain may also alter the MCM hexamer oligomeric state. Alternatively, the domain may directly block the access of activating factors.
The fact that mcm4 D2-174 scored negative in the stringent assay for DDK-independent cell proliferation is consistent with our previous finding that it executes the function of MCM4 poorly 18 . In contrast, mcm4 D74-174 exhibited the best growth on 5-FOA medium in the same experiment ( Fig. 2a) , indicating that the distal part of the Mcm4 NSD (residues 2-73) has a positive role in supporting DDK-independent growth. A shorter version (residues 2-37) could function similarly ( Supplementary Fig. 3 ). The distal NSD of Mcm4 is serine/threonine (S/T) rich and contains four CDK target (S/T-P) sites 20 , all of which are preceded by additional S/Ts (Fig. 2b) 
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Empty vector TSSSS163-176AAAAA, S171A, S174A TSSSS163-176DDDDD, S171D, S174D SSSS164-176DDDD, S171D, S174D DDK-independent cell proliferation. a-c, A modified plasmid shuffle assay was used to identify MCM4 alleles that allow cell growth in the absence of CDC7 and MCM4 when expressed from single-origin vectors. The tester yeast strain was constructed with both MCM4 and CDC7 genes deleted from its chromosomes while carrying both essential genes on plasmids with the URA3 gene that can be counter-selected in the presence of 5-FOA. The tester cells were transformed with indicated plasmids and assayed for growth on YPD and 5-FOA media. All mcm4 alleles used in the assay complement mcm4D. a, DDK-independent cell growth by the mcm4 mutants described in Fig. 1 . b, Top panel, diagram of mcm4 D74-174 derivatives with mutations at CDK phosphorylation sites and their preceding phospho-acceptor residues within the distal NSD (residues 2-73). Bottom panel, the ability of mcm4 alleles described above to support DDK-independent growth. c, DDKindependent cell growth supported by mcm2 1-200 -mcm4 D2-174 .
would become favourable phospho-acceptors for DDK following priming phosphorylation 21, 22 . Converting all four CDK sites to alanines within mcm4 D74-174 (mcm4 D74-174, 4(SPRAP) ) had little effect on its ability to rescue mcm4D ( Fig. 2b and Supplementary Fig. 5 ). However, this mutant failed to bypass DDK. In contrast, phosphomimetic substitution of these sites (mcm4 D74-174, 4(SPRDP) ) allowed DDK-independent growth and additional phosphomimetic substitutions of all the preceding S/Ts further improved the growth (Fig. 2b) . One caveat is that constitutive phosphorylation or phosphomimetic substitution may compromise other aspects of Mcm4 function in DNA replication (see Supplementary Fig. 10 ). As a result, the phosphomimetic derivatives of mcm4 D74-174 do not support growth better than mcm4 D74-174 which is regulated by phosphorylation. Nevertheless, the positive function within the distal NSD may depend on phosphoregulation by CDK, and possibly by DDK. In the absence of DDK, CDK control of this region becomes essential. It remains to be addressed whether additional kinases also contribute to regulation of the Mcm4 NSD, which also contains several potential ATM/ATR target (S/T-Q) sites and many of these are also preceded by stretches of S/Ts. Other MCM subunits such as Mcm2 and Mcm6 have also extended unstructured amino-terminal domains (NTDs) harbouring DDK target sites ( Supplementary Fig. 6a ). However, none of the N-terminal deletion mutants of MCM2 or MCM6 tested supported DDK-independent cell growth using analogous plasmid shuffle assays ( Supplementary Fig. 6b and c) . Thus, the inhibitory activity may be a unique feature of Mcm4. Yet, we have previously demonstrated that the NTD of Mcm2 can functionally replace the Mcm4 NSD in supporting normal cell proliferation and timely S phase progression 18 . The mcm2 1-200 -mcm4 D2-174 fusion can function as an mcm4 allele that supports DDK-independent cell proliferation to an extent that surpasses mcm4 D74-174 ( Fig. 2c and Supplementary Fig. 7a ). Therefore, the Mcm2 NTD has a positive role in activating DNA replication. This region contains .30% negatively charged aspartic acid (D) and glutamic acid (E) residues, reminiscent of phosphorylated S/Ts. Thus, the Mcm2 NTD may act like a phosphorylated distal NSD of Mcm4.
DDK-bypass alleles of MCM4 were introduced into the endogenous locus in subsequent experiments. mcm4 D74-174 , mcm2 1-200 -mcm4 D2-174 and mcm5-bob1 cells grew at the same rate as the wild type cells ( Supplementary Fig. 7a and b ). The proliferation rates of cdc7D mcm4 D74-174 and cdc7D mcm5-bob1 were comparable. Consistent with earlier observations (Fig. 2a, c) , cdc7D mcm2 1-200 -mcm4 D2-174 cells proliferated faster than cdc7D mcm4 D74-174 cells, whereas cdc7D mcm4 D2-174 cells proliferated more slowly ( Supplementary Fig. 7b ). Cells without DDK grew slowly, entered S phase later and progressed through S phase at slower rates than their DDK positive counterparts (Fig. 3a) . These results indicate that DDK has other non-essential roles in regulating S phase progression in addition to alleviating the inhibitory activity within the proximal NSD. For example, DDK may phosphorylate the distal NSD of Mcm4 or other substrates for efficient S phase progression.
One important consequence of DDK action during S phase is formation of a stable complex between Cdc45 and MCM at each origin as it is activated 18, [23] [24] [25] . To determine if mcm4 D74-174 can bypass the requirement of DDK for Cdc45-MCM complex formation, coimmunoprecipitation of Cdc45 with Mcm2 antibodies in cdc7D mcm4 D74-174 cells, mcm4 D74-174 and wild type cells was examined. Cells were synchronized to allow progression through the cell cycle from G1 at 25 uC (Fig. 3a) . The Cdc45-MCM complex was detected at similar intensity and kinetics in wild type and mcm4 D74-174 cells, with a peak at ,40 min after G1 release (Fig. 3b ). In the cdc7D mcm4 D74-174 cells, the complex appeared at a later time (at ,60 min, peak at ,80 min) and at reduced levels. Nevertheless, these results demonstrated that eliminating the inhibitory domain in the Mcm4 NSD allows the Cdc45-MCM complex to form in the absence of DDK, but DDK is still needed for timely Cdc45-MCM association under this bypass condition.
Recent studies reported conditions that allow yeast cells to replicate DNA in the absence of S-CDKs 6,7 . For example, the requirement for S-CDK for DNA synthesis can be bypassed by combining an sld3-dpb11 fusion (SD fusion) and overexpression of a phospho-mimetic sld2-T84D mutation 7 . Under this S-CDK bypass condition, DDK is limiting for DNA replication and overexpression of DBF4 is necessary for extensive DNA synthesis in a-factor arrested, G1 cells. Instead of Dbf4 over-production, replacing the chromosomal MCM4 with mcm4 D74-174 in this S-CDK bypass system allowed a similar extent of DNA replication in G1 ( Fig. 3c and Supplementary Fig. 8 ). We also observed a modest but consistent DDK-independent increase of DNA content in G1 by introducing mcm4 D74-174 to a different S-CDK bypass condition 6 ( Supplementary Fig. 9 ). Furthermore, unlike another DDK bypass mutation mcm5-bob1, mcm4 D74-174 does not exhibit synthetic lethality with SD fusion. Thus, DDK bypass is not necessarily synthetically lethal with SD fusion as previously suggested 7 15, [17] [18] [19] 21, 22, 24, 26 . Because MCM4 does not cause lethality in mcm5-bob1 cells lacking DDK, mcm5-bob1 is epistatic to MCM4 in this condition. Thus, DDK bypass by mcm5-bob1 is probably downstream of the inhibitory function of the Mcm4 NSD.
In the presence of DDK, mcm4 D2-174 cells, but not mcm4 D74-174 or mcm2 1-200 -mcm4 D2-174 cells, were sensitive to the ribonucleotide reductase inhibitor hydroxyurea (Fig. 4a) , indicating that the distal Mcm4 NSD or its functional equivalent (for example, NTD of Mcm2) is required under DNA-damaging conditions. Like cdc7D mcm5-bob1 cells 19 , cdc7D mcm4 D2-174 , cdc7D mcm4 D74-174 and cdc7D mcm2 1-200 -mcm4 D2-174 cells were not viable in hydroxyurea (Fig. 4a) . Thus, mcm4 D74-174 and mcm2 1-200 -mcm4 D2-174 do not bypass the requirement of DDK for growth in the presence of hydroxyurea. We examined checkpoint activation under synchronous G1 to hydroxyurea release by monitoring Rad53 hyper-phosphorylation ( Fig. 4b and c ). Although checkpoint activation in MCM4 and mcm4 D74-174 cells was efficient, Rad53 hyper-phosphorylation was not detectable in cdc7D mcm4 D74-174 cells over the course of 3 h in 200 mM hydroxyurea. A similar defect in checkpoint activation in S phase was also found in cdc7D mcm5-bob1 cells 27 . Although it is conceivable that insufficient initiation in cdc7D mcm4 D74-174 cells would evade the checkpoint 28 , hydroxyurea treatment of the asynchronous cdc7D mcm4 D74-174 culture, which accumulates a large population of S phase cells, still failed to elicit robust Rad53 phosphorylation, unlike the response of the asynchronous mcm4 D74-174 culture (Fig. 4c ). Thus, it remains possible that DDK is required for the checkpoint response through Rad53 under replication stress ( Supplementary  Figs 11 and 12 ). Overall, our results demonstrate that mcm4 D74-174 can bypass the requirement for DDK in an unperturbed S phase, but it cannot bypass the requirement for DDK in proper intra-S-phase checkpoint response.
Cell fusion experiments indicated that ''certain substances which are present in the S component probably migrate into G1 nucleus and cause initiation of DNA synthesis'' 8 . The results presented here for DDK and elsewhere for CDK 6, 7, 14 have uncovered essential targets for such activators that must act on the competent pre-replicative complex. One surprising finding is that the essential DDK activity is to inhibit an intrinsic inhibitor of initiation of DNA replication. Our study shows that the unstructured Mcm4 NSD is a multi-function domain that may serve to integrate various signals to regulate eukaryotic DNA replication.
METHODS SUMMARY
Yeast genetic methods and strain construction, cell extract preparation, immunoprecipitation, immunoblot analysis and antibodies are described in detail in Methods. Conditions of cell growth, cell cycle block and synchronization, and flow cytometry analysis are similar to published methods 6, 7, 18, 19 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. phosphorylation status in wild type, mcm4 D74-174 and cdc7D mcm4 D74-174 cells. b, Protein samples were prepared from cells synchronized in G1 and released into 200 mM hydroxyurea for the indicated time. c, Protein samples were prepared from log-phase cells treated with hydroxyurea for the indicated time.
